(Reuters) -CoreWeave said on Thursday it was targeting a valuation of up to $26 billion in its U.S. initial public offering, ...

For the first time, scientists say, they have evidence that using a biologic drug to remove sticky beta amyloid plaques from ...

Chelsea have managed to avoid a points deduction for breaching the Premier League’s Profit and Sustainability rules, but they ...